Profil
Patrick van Berkel currently works at ADC Therapeutics SA, as Chief Scientific Officer.
Dr. van Berkel also formerly worked at Genmab A, as VP-Antibody, Technology & Chemistry from 2003 to 2012.
Dr. van Berkel received his doctorate degree in 1998 from the University of Leiden and undergraduate degree in 1991 from Radboud University Nijmegen.
Postes actifs de Patrick van Berkel
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur Technique/Scientifique/R&D | 01/08/2012 |
Anciens postes connus de Patrick van Berkel
| Sociétés | Poste | Fin |
|---|---|---|
| GENMAB A/S | Directeur Technique/Scientifique/R&D | 01/01/2012 |
Formation de Patrick van Berkel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
















